We previously described a group of patients with recurrent herpes labialis who underwent biopsy for the evaluation of recurrent genital herpes. We report the first case of a patient with recurrent genital herpes who was subsequently treated with the use of a novel immunotherapy, aciclovir. This case illustrates the possibility of a different type of herpes, i.e. a combination of aciclovir and clomiphene, where the former is the best available treatment for recurrent genital herpes. The mechanism of action of aciclovir, therefore, remains to be elucidated.
The clinical presentation of recurrent herpes is significantly different from that of recurrent genital herpes. A large proportion of the patients with recurrent genital herpes, both in themselves and in the community, are in the early stages of the disease. A previous study found that the presence of recurrent genital herpes in this patient was associated with an increased risk of developing an episode of genital herpes. Although we can clearly demonstrate the efficacy of aciclovir as an alternative agent for the treatment of recurrent genital herpes, there is still much to be studied and the results of this study should be interpreted with caution.
The present case is the first to describe the effect of an aciclovir-treated patient with recurrent genital herpes who was subsequently treated with the use of an oral aciclovir-containing formulation. This is a novel formulation of aciclovir, a widely used oral antiviral agent, that has been used as the initial treatment of recurrent genital herpes for many years.
Consequently, the patient presented with recurrent genital herpes, which was initially characterized by recurrent episodes. He was subsequently treated with an oral aciclovir-containing formulation. Although the patient presented with recurrent genital herpes during the initial episode of the disease, the clinical presentation and the response to treatment were not different. Therefore, the diagnosis of recurrent genital herpes was made through an immunotherapy. As the patient’s initial episode was characterized by recurrent episodes, the immunotherapy was initiated and then continued. He was subsequently diagnosed with recurrent genital herpes.
Chen K-Hang et al. (2015) Effect of a new formulation of the fluoroquinolone-class of antimicrobials, including aciclovir, on recurrent genital herpes in a patient with recurrent genital herpes. Clin Nerv Pharmacol. 15(7): 1425–1440.doi: 10.1111/clnph.12063. Accessed September 15, 2015.
https://medicalxpress.com/news/2015-09-recurrent-gene-bacteriote-infection-recurrent-gene.html
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/public/publica/v5/cw) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited.Zovirax is a prescription medicine that belongs to a class of drugs called antivirals. Zovirax contains aciclovir as its active ingredient and has potent antiviral activity. This medication is mainly used for the treatment of viral infections like genital herpes, cold sores, and chickenpox.
If you are diagnosed with the herpes virus, start the therapy as soon as possible or at the first sign of an outbreak. Your doctor may prescribe you Zovirax tablets depending on your age and medical condition. The tablets are taken orally with or without food.
Take the medication at the same times every day for maximum benefit. Do not skip any dose, or stop this medication early without consulting your doctor. Always drink enough water while taking Zovirax to prevent the chances of dehydration and kidney damage.
Patients may experience some common side effects after taking Zovirax, including:
Contact your doctor immediately if you notice any serious side effects, including:
Tablets:Aciclovir 200 mg (1 tablet) - Zovirax, Ciprofloxacin, Ofloxacin, Ofloxacin Injection - Topical ophthalmic solution.
Directions:Adults and children 12 years and over: take 1 tablet orally every day, as directed by your doctor. Use it as prescribed. Do not take more or less of it. Use this medicine in the dose and duration as prescribed. The dose may be increased as necessary. Do not use if you are pregnant or breastfeeding, if you are allergic to aciclovir, if you have liver problems or any other health problem. If aciclovir is given to an infant, it should be used only when clearly needed during the first few months of life. Aciclovir may be given in any dose and for a long time. Your doctor will decide how you should take this medicine. Do not take this medicine on an empty stomach or after a high-fat meal.
Ingredients:Each tablet contains 400 mg aciclovir, 400 mg of valaciclovir, 2 g of ophthalmic ointment, for injection in the eye, for the treatment of herpes labialis infection.
Contains:Aciclovir
Warnings:Do not use this medicine after the expiry date printed on the pack. Exclusions and warnings
Please read the enclosed leaflet carefully before use.
Keep out of the reach of children.
This medicine contains an active ingredient, valacyclovir.Directions for use:
Take this medicine by mouth with a glass of water. Do not crush, break or chew the tablet. Swallow the whole with a full glass of water. Do not use if the blister is open. Do not use if the blister does not contain any film-coated tablets.
Do not give this medicine to anyone less than 18 years of age.
Keep this medicine out of the reach of children.
This medicine contains an active ingredient, aciclovir.Do not use if the expiry date printed on the pack has passed. Read the enclosed leaflet carefully before use.
If you are unsure whether this medicine is suitable for you, talk to your doctor or pharmacist or your pharmacist.
If you cannot swallow the tablets, you should not use this medicine. You should also not use this medicine if you have liver problems.
Acyclovir 400mg/5ml injection (ACV) for treatment of herpes labialis is an antiviral agent. It is indicated for the treatment of acute and subacute herpes labialis infections in adults and in the prevention of herpes labialis in children. In this randomized, controlled, double-blind, placebo-controlled study, aciclovir was given at a dose of 400mg/5ml for a period of 12 months. Acyclovir 400mg/5ml injection was administered to 30 patients with herpes labialis: 7 of 15, 6 of 40, and 8 of 72 with recurrent herpes labialis; and 5 of 8 with acute sores. Aciclovir was also given at a dose of 800mg/5ml for a period of 8 months. Patients were randomly assigned to receive the treatment regimen of either 100mg aciclovir or placebo at the start of treatment. Patients were instructed to receive either 50mg aciclovir or placebo every 12 months until no further treatment was completed. The primary endpoints were change in laboratory values during the 12 months follow-up. Statistical analysis was done using the intention-to-treat (ITT) method. Patients were required to complete the 12-month study; however, the patient population was not different from the control group.
Aciclovir is a topical (cream) antiviral cream used to treat shingles, herpes simplex virus infections, and cold sores. It is available in a blister pack or tablet form.
If you have herpes, the active ingredient in aciclovir may not be safe to use (it can make your skin more sensitive). It is also possible that you could experience side effects from taking aciclovir. If you have any concerns, make sure to speak to your healthcare provider.
Aciclovir (generic name: acyclovir) is used to treat shingles, cold sores, genital herpes, and genital herpes caused by the herpes simplex virus (HSV).
It is usually taken for five days. The active ingredient, aciclovir, is usually taken in the morning (about
).
When used for shingles, it is most effective for children. It can be used as soon as the onset of symptoms occurs, however, it can take longer to be effective. If you have a cold sore, it is usually used for five days, as opposed to five days for shingles.